A carregar...
Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data
Glucagon-like peptide-1 (GLP-1) receptor agonists have been available as glucose-lowering therapies for people with type 2 diabetes since 2006, when twice-daily exenatide was licenced. Since then, advances in peptide chemistry and delivery have allowed for once-daily and more recently once-weekly (Q...
Na minha lista:
| Publicado no: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7035886/ https://ncbi.nlm.nih.gov/pubmed/32110076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S193693 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|